- Home
- OABI vs BRT Comparison
OABI vs BRT Comparison
Compare OABI & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OABI | BRT |
|---|---|---|
| Founded | 2012 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 277.8M | 285.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OABI | BRT |
|---|---|---|
| Price | $1.84 | $14.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $6.67 | ★ $19.75 |
| AVG Volume (30 Days) | ★ 424.6K | 35.3K |
| Earning Date | 03-17-2026 | 03-11-2026 |
| Dividend Yield | N/A | ★ 6.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $21,094,000.00 | ★ $98,001,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $66.20 | $3.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.36 | 1.30 |
| 52 Week Low | $1.22 | $14.00 |
| 52 Week High | $4.02 | $19.01 |
Technical Indicators
Market Signals| Indicator | OABI | BRT |
|---|---|---|
| Relative Strength Index (RSI) | 49.03 | 51.81 |
| Support Level | $1.67 | $14.51 |
| Resistance Level | $1.86 | $15.10 |
| Average True Range (ATR) | 0.11 | 0.29 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 43.01 | 61.69 |
Price Performance
Historical ComparisonAbout OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.